JAAPA · 2018 · 57 citations · 9 references
Sexual HealthPsychiatrySexual And Reproductive HealthSexual EventsPharmacologySexual DysfunctionGynecology5-Ht2a AntagonistPharmacotherapySexual PsychophysiologyPremenopausal WomenWomen's PhysiologyEndocrinologyMedicineSocial SciencesWomen's HealthMixed 5-Ht1a Agonist
Flibanserin is a mixed 5-HT1A agonist and 5-HT2A antagonist for treatment of premenopausal women with hypoactive sexual desire disorder. It is the first FDA-approved treatment for this disorder and can improve the number of satisfying sexual events. The drug has been associated with hypotension and syncope.
9